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Abstract
Background: The aim of this study is to investigate predictive factors for intensive care unit (ICU) admission among
patients with severe leptospirosis.
Methods: This is a retrospective study with all patients with severe leptospirosis admitted to a tertiary hospital.
Patients were divided in ICU and ward groups. Demographical, clinical and laboratory data of the groups were
compared as well as acute kidney injury (AKI) severity, according to the RIFLE criteria (R = Risk, I = Injury, F = Failure,
L = Loss, E = End-stage kidney disease).
Results: A total of 206 patients were included, 83 admitted to ICU and 123 to ward. Mean age was 36 ± 15.8 years,
with 85.9 % males. Patients in ICU group were older (38.8 ± 15.7 vs. 34.16 ± 15.9 years, p = 0.037), had a shorter hospital
stay (4.13 ± 3.1 vs. 9.5 ± 5.2 days, p = 0.0001), lower levels of hematocrit (29.6 ± 6.4 vs. 33.1 ± 8.6 %, p = 0.003),
hemoglobin (10.2 ± 2.4 vs. 11.6 ± 1.9 g/dL, p < 0.0001), and platelets (94,427 ± 86,743 vs. 128,896 ± 137,017/mm3,
p = 0.035), as well as higher levels of bilirubin (15.0 ± 12.2 vs. 8.6 ± 9.5 mg/dL, p = 0.001). ICU group also had a
higher frequency of severe AKI (RIFLE-“Failure”: 73.2 % vs. 54.2 %, p < 0.0001) and a higher prevalence of
dialysis requirement (57.3 % vs. 27.6 %, p < 0.0001). Mortality was higher among ICU patients (23.5 % vs.
5.7 %, p < 0.0001). Independent predictors for ICU admission were tachypnea (p = 0.027, OR = 13, CI = 1.3–132),
hypotension (p = 0.009, OR = 5.27, CI = 1.5–18) and AKI (p = 0.029, OR = 14, CI = 1.3–150). Ceftriaxone use was a
protective factor (p = 0.001, OR = 0.13, CI = 0.04–0.4).
Conclusions: Independent risk factors for ICU admission in leptospirosis include tachypnea, hypotension and
AKI. Ceftriaxone was a protective factor for ICU admission, suggesting that its use may prevent severe forms
of the disease.
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Background
Leptospirosis is one of the most important zoonosis in the
world [1]. The disease may manifest as a broad spectrum of
signs and symptoms, with a sudden onset of headache,
high-degree fever, malaise, myalgia, conjunctival suffusion
and transient rash [1]. The severe form is characterized by
jaundice, acute kidney injury (AKI) and hemorrhage, par-
ticularly in the lungs, known as Weil’s disease [1, 2]. It is
mainly caused by serovars Icterohaemorrhagiae, Copenha-
geni, Lai and others [1, 2]. Mortality from severe leptospir-
osis is high, ranging from 5 to 20 %, even when optimal
treatment is provided3. Leptospirosis-associated AKI has
peculiar characteristics: it is usually non-oliguric and associ-
ated with hypokalemia or normokalemia [1, 3, 4].
Intensive Care Unit (ICU) admission is often necessary
for patients with severe leptospirosis. In a recent Brazilian
study, leptospirosis was among the most frequent infectious
diseases that required ICU [5]. Mortality rates remain high,
despite of treatments instituted [3, 6]. It was demonstrated
that early dialysis reduces mortality and complications asso-
ciated with leptospirosis in the ICU [7].
Early identification of severe or potentially severe
cases of leptospirosis, and then possible ICU admis-
sion need, is of crucial importance to enhance more
aggressive treatment and decrease mortality, which is
still unacceptable high in this disease. As leptospirosis
is endemic in many tropical and developing countries,
a more adequate classification and approach to pa-
tients can probably impact on economic issues. A
mortality decrease in leptospirosis, for example, is
favorable to labor, once great part of leptospirosis
patients are young man, and it is possible to avoid
years of life lost.
Hence, the aim of this study was to investigate predict-




The study included all patients with confirmed diagnosis of
severe leptospirosis (Weil’s disease) consecutively admitted
to São José Infectious Diseases Hospital, in Northeast
Brazil, from 2000 to 2013. Study Design
This is a cross-sectional study. Data on hospital admis-
sion were obtained from medical records. They were
initially admitted to the emergency department, and
then transferred to another unit (ward or ICU). We also
grouped these patients according to the site of care:
those transferred to the ICU and to ward. A comparison
of demographical, clinical and laboratory data between
the two groups was performed in order to investigate
differences between them and factors associated with
ICU admission.
Case definition
Leptospirosis cases were defined as the presence of posi-
tive serology through microscopic agglutination test
(MAT) higher than 1:800. All patients had also epidemio-
logical and clinical history compatible with leptospirosis.
Inclusion criteria
Inclusion criteria were: patients ≥ 18 years-old, positive
serology for leptospirosis, admission at São José Infec-
tious Diseases Hospital during the study period.
Exclusion criteria
Exclusion criteria were: patients ≤ 18 years-old, negative
serology for leptospirosis, incomplete data on medical
records, referral to other hospitals and hospital stay less
than 24 h.
Studied parameters
Demographic characteristics such as age, gender, time
between initial symptoms and hospital admission as well
as length of hospital stay were recorded. The clinical in-
vestigation included a record of all clinical signs and
symptoms presented by each patient on hospital admis-
sion and during hospital stay, medications used, dialysis
requirement and co-infections.
Laboratory data on hospital admission included an as-
sessment of serum urea, creatinine, sodium, potassium,
total bilirubin, direct bilirubin, indirect bilirubin, aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
lactate dehydrogenase (LDH), hemoglobin, hematocrit,
leukocyte count, platelets count and arterial blood gas
analysis.
Definitions
Acute kidney injury (AKI) was defined according to RIFLE
criteria (R = Risk, I = Injury, F = Failure, L = Loss, E = End-
stage kidney disease) [8]. Thrombocytopenia was defined as
platelets count lower than 150,000/mm3 and anemia as
hemoglobin <12 g/dL. The occurrence of metabolic acid-
osis was considered when pH < 7.35 and HCO3 < 20 mEq/
L, and severe metabolic acidosis when pH < 7.10. Tachyp-
nea was defined as a respiratory rate higher than 25 per
minute. Oliguria was defined as urine output < 400 ml/day
after 24 h of effective hydration. Hypotension was defined
as mean arterial blood pressure (MAP) < 60 mmHg,
and therapy with vasoactive drugs was initiated when
MAP remained lower than 60 mmHg despite the use
of endovenous fluids. Hypertension was defined as
systolic pressure ≥130 mmHg and/or diastolic pres-
sure ≥85 mmHg.
Statistical analysis
The results were expressed through tables, mean ±
standard deviation (SD). All data were analyzed with
De Francesco Daher et al. BMC Infectious Diseases  (2016) 16:40 Page 2 of 7
the program SPSS version 20.0 (Chicago, IL, USA).
Comparison between the two groups was performed
using Pearson’s Chi-square test and Student’s T test.
Mann–Whitney test was used for parameters with a
non-normal distribution. A logistic regression model
was used for quantitative variables. Adjusted odds
ratios (OR) and 95 % confidence intervals (CI) were
calculated. A multivariate logistic regression was per-
formed to analyze the possible risk factors associated
with ICU admission. The parameters included in the
multivariate model were those that showed a signifi-
cance level in the univariate analysis. Significance level
was set at 5 % (p values ≤ 0.05).
Ethics
The protocol of this study was approved by the Ethics




Among 206 patients included in the study, eighty-three
were included in the ICU group and 123 in the ward
group. There was a predominance of males (85.9 %), and
mean age was 36 ± 15.8 years. Complete evaluation of
demographic data is presented in Table 1.
Signs and symptoms at admission
Main signs and symptoms at hospital admission were
fever (87.1 %), myalgia (77.2 %), jaundice (71.7 %), head-
ache (65.5 %), calf pain (48.5 %), asthenia (45.0 %) and
diarrhea (41.5 %). Higher levels of heart and respiratory
rates were observed in ICU group (105.0 ± 19.5 vs. 94.7 ±
19.0/min, p = 0.008; 31.8 ± 13.0 vs. 25.0 ± 8.8/min, p =
0.004, respectively), as well as lower levels of systolic blood
pressure (106.3 ± 27 vs. 115.2 ± 18 mmHg, p = 0.018), as
summarized in Table 2.
Comparison between ICU and ward group
Patients in the ICU group were older than ward group
(38.8 ± 15.7 vs. 34.2 ± 15.9 years, p = 0.037). Average
length of hospital stay was shorter in the ICU group
(4.13 ± 3.1 vs. 9.5 ± 5.2 days, p = 0.001). Patients admitted
to ICU also presented lower levels of hematocrit (29.6 ±
6.4 vs. 33.1 ± 8.6 %, p = 0.003), hemoglobin (10.2 ± 2.4 vs.
11.6 ± 1.9 g/dL, p < 0.0001), platelets (94,427 ± 86,743 vs.
128,896 ± 137,017/mm3, p = 0.035), as well as higher
levels of total bilirubin, direct and indirect bilirubin
(15.0 ± 12.2 vs. 8.6 ± 9.5 mg/dL, p = 0.001; 9.2 ± 8.5 vs.
5.9 ± 7.1 mg/dL, p = 0.018; 4.5 ± 6.1 vs. 2.4 ± 3.2 mg/dL,
p = 0.013, respectively) on hospital admission, as sum-
marized in Table 3. ICU patients also presented higher
prevalence of hypertension (68.0 vs. 43.9 %, p = 0.006),
hypotension (66.0 vs. 33.3 %, p < 0.0001), metabolic acid-
osis (60.5 vs. 36.5 %, p = 0.011) and severe metabolic
acidosis (11.0 vs. 0 %, p = 0.02) on hospital admission.
ICU group had higher levels of serum creatinine (3.97 ±
2.25 vs. 2.97 ± 2.4 mg/dL, p = 0.004) and serum urea
(131.8 ± 68 vs. 101.2 ± 72.5 mg/dL, p = 0.004) on hospital
admission. Oliguria was not significantly different between
ICU group and ward group (22.9 % v. 26.8 %, p = 0.699,
respectively). The ICU group also presented higher preva-
lence of AKI (93.9 % vs. 69.9 %, p < 0.0001), with a higher
Table 1 Comparison of demographic data between patients






Age (years) 38.8 ± 15.7 34.1 ± 15.9 0.037
Gender
Male 72 (86.7 %) 105 (85.4 %) 0.840
Female 11 (13.3 %) 18 (14.6 %)
Hospital stay (days) 4.13 ± 3.1 9.5 ± 5.2 0.0001
Time between onset of
symptoms and
hospitalization (days)
7 ± 4 7.22 ± 4.11 0.224
Mortality (%) 23.5 5.7 <0.0001
Pearson’s Chi-square test, T-Student test and Mann–Whitney test were used to
perform this comparison. P values ≤ 0.05 were considered
statistically significant
Table 2 Comparison of signs, symptoms and vital signs among
patients with severe leptospirosis admitted to ICU and ward
ICU (N = 48) Ward (N = 123) p
Signs and symptoms
Choluria 7 (16.6 %) 54 (44.7 %) 0.001
Crackles 1 (2.1 %) 15 (13 %) 0.043
Diarrhea 12 (25 %) 52 (42.3 %) 0.855
Dyspnea 18 (37.5 %) 33 (27.6 %) 0.287
Fever 33 (68.8 %) 115 (94.3 %) <0.0001
Hematemesis 7 (14.6 %) 7 (5.7 %) 0.068
Hematuria 3 (8.3 %) 8 (7.3 %) 0.759
Hemoptysis 8 (16.7 %) 9 (8.1 %) 0.625
Jaundice 30 (64.5 %) 87 (71.5 %) 0.998
Myalgia 27 (58.3 %) 104 (84.6 %) <0.0001
Oliguria 10 (22.9 %) 32 (26.8 %) 0.699
Conjunctival suffusion 4 (10.4 %) 22 (17.9 %) 0.305
Tachypnea 15 (33.3 %) 15 (13 %) 0.004
Vital signs
SBP (mmHg) 106.28 ± 27 115.17 ± 18 0.018
DBP (mmHg) 64.53 ± 18.7 71.3 ± 14.8 0.18
HR (/min) 105.03 ± 19.5 94.7 ± 19.05 0.008
RR (/min) 31.8 ± 13 25 ± 8.78 0.004
SBP systolic blood pressure, DBP diastolic blood pressure, HR Heart Rate, RR
Respiratory Rate. Pearson’s Chi-squared test, T-Student test and Mann–Whitney
test were used. P values ≤ 0.05 were considered statistically significant
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number of severe forms according to RIFLE criteria
(“Risk” 4.9 % vs. 7.5 %, “Injury” 17.1 % vs. 10.0 % e “Fail-
ure” 73.2 % vs. 54.2 %, p < 0.0001). Need of dialysis was
more frequent in this group (57.3 % vs. 27.6 %, p < 0.0001)
when compared to ward group, as presented in Table 4.
Treatment
Need of vasoconstrictors and use of diuretics were higher
in ICU group (57.8 vs. 12.3 %, p < 0.0001; 49.4 vs. 26.1 %,
p = 0.006, respectively). Ceftriaxone use was significantly
higher in the ward group (67.6 vs. 41 %, p = 0.009), while
the use of crystalline penicillin was similar in both groups,
as summarized in Table 5.
Risk factors for ICU admission
In multivariate analysis, independent predictors for ICU
admission were: tachypnea (p = 0.027, OR: 13, CI = 1.3 -
132), hypotension (p = 0.009, OR: 5.27, CI = 1.5 - 18) and
AKI severity (p = 0.029, OR: 14, CI = 1.3 - 150). On the
other hand, ceftriaxone use was a protective factor (p =
0.001, OR = 0.13, CI = 0.04 – 0.4) for ICU admission, as de-
scribed in Table 6.
Mortality
Overall mortality was 12.7 %, and it was higher in ICU
group (23.5 vs. 5.7 %, p < 0.0001).
Discussion
Predictors for ICU admission among patients with severe
leptospirosis include tachypnea, hypotension and severe
AKI, which can be identified at hospital admission and
then subside requirement for a more aggressive treatment.
The use of ceftriaxone was a protective factor against ICU
admission, which suggests an important effect on decreas-
ing disease severity.
Leptospirosis is a public health problem, with higher
prevalence in tropical areas, including Brazil [4, 9]. The dis-
ease can present with severe manifestations and high mor-
tality. Therefore it is important to characterize predictors of
intensive care need in order to early identify potentially fatal
cases and to provide a more careful approach. This is the
first study in our region to investigate the differences be-
tween patients with leptospirosis admitted to a ward service
and ICU.
In the present study patients admitted to the ICU were
older, which may reflect an association between ad-
vanced age and disease severity, as previously reported
[10–12]. In a recent study from India, older age was a
Table 3 Comparison of laboratory data between patients with
severe leptospirosis admitted to ICU and wards
Parameters ICU Non-ICU p
N = 83 N = 123
Creatinine (mg/dl) 3.97 ± 2.25 2.97 ± 2.4 0.004
Urea (mg/dl) 131.8 ± 68 101.2 ± 72.5 0.004
Potassium (mEq/L) 3.91 ± 0.85 3.9 ± 1.07 0.951
Sodium (mEq/L) 133 ± 6.61 130 ± 19 0.317
AST (UI/L) 169.8 ± 199 132.13 ± 183 0.285
ALT (UI/L) 101.83 ± 90 101.90 ± 153 0.998
LDH (UI/L) 810.25 ± 539 671.94 ± 420 0.416
Total bilirubin (mg/dl) 15 ± 12.2 8.6 ± 9.5 0.001
Direct bilirubin (mg/dl) 9.2 ± 8.5 5.9 ± 7.11 0.018
Indirect bilirubin (mg/dl) 4.48 ± 6.08 2.38 ± 3.22 0.013
Hematocrit (%) 29.6 ± 6.4 33.1 ± 8.63 0.003
Hemoglobin (g/dl) 10.2 ± 2.4 11.6 ± 1.95 <0.001
WBC (103/mm3) 14.30 ± 7.70 14.95 ± 1.82 0.772
Platelets (103/mm3) 94.42 ± 86.74 128.89 ± 137.01 0.035
pO2 (mmHg) 87.3 ± 32 83 ± 34 0.542
pCO2 (mmHg) 31.81 ± 9.4 32.64 ± 8.5 0.636
pH 7.35 ± 0.08 7.36 ± 0.07 0.127
Bicarbonate (mEq/L) 17.89 ± 4.82 18.8 ± 4.89 0.330
SaO2 (%) 93.82 ± 5.7 91.6 ± 10.17 0.190
AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate
dehydrogenase, WBC white blood cells, PO2 O2 partial pressure, PCO2 PCO2
partial pressure, SaO2 O2 saturation
Chi-squared test, T-Student test and Mann–Whitney test were used to perform
this comparison. Values expressed as mean ± SD and percentage. P values ≤
0.05 were considered statistically significant
Table 4 Comparison of acute kidney injury and dialysis
requirement between patients with severe leptospirosis
admitted to ICU and wards
ICU (N = 83) Ward (N = 123) p
AKI 77 (93.9 %) 85 (69.9 %) <0.0001
Dialysis 47 (57.3 %) 33 (27.6 %) <0.0001
RIFLE
Risk 3 (4.9 %) 9 (7.5 %)
Injury 14 (17.1 %) 12 (10 %) <0.0001
Failure 60 (73.2 %) 66 (54.2 %)
Chi-square test was performed to make this comparison. P values ≤ 0.05 were
considered statistically significant
Table 5 Comparison of treatments instituted for patients with
severe leptospirosis admitted to ICU and ward
ICU (N = 83) Ward (N = 123) p
Hemoderivatives 44 (54 %) 58 (47.7 %) 0.052
Vasoconstrictors 47 (57.8 %) 15 (12.3 %) <0.0001
Ceftriaxone 34 (41 %) 83 (67.6 %) 0.009
Penicillin 48 (59 %) 60 (49.1 %) 0.354
Diuretics 41 (49.4 %) 32 (26.1 %) 0.006
Pearson’s Chi-squared test was used to make the comparison. P values ≤ 0.05
were considered statistically significant
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predictor of mortality in leptospirosis [3]. Leptospirosis
in elderly patients was associated with severe course and
increased risk of mortality, mostly due to the high inci-
dence of comorbidities in this population [12].
The length of hospital stay was shorter in ICU pa-
tients, and this is probably due to a high mortality in
cases that demand intensive care. We observed that
more critically ill patients usually died during the first
days of ICU admission, despite early treatment. Previous
studies have shown that early daily dialysis in patients
with leptospirosis-associated AKI reduces mortality and,
therefore, it would probably be beneficial in critically ill
patients [7, 13].
In the present study, ICU patients presented higher
levels of total, direct and indirect bilirubin than ward
patients. In a French study with leptospirosis patients,
bilirubinemia was higher in severe cases and jaundice
was demonstrated to be a predictive factor of severity in
leptospirosis according to multivariate analysis (p =
0.005, OR = 10.1, CI = 1.79 – 56.8) [14]. In this same
study, dyspnea (respiratory rate > 24/min) was higher in
severe cases (p < 0.0001). These findings confirm the
data in our study and reinforce the role of tachypnea as
independent predictor for ICU admission, according to
multivariate analysis.
We have found higher prevalence of anemia and
thrombocytopenia as well as higher levels of urea and cre-
atinine in the ICU group. Thrombocytopenia is frequent in
leptospirosis and contributes to hemorrhagic phenomena
[2, 15]. Although rare, pancytopenia can also be found in
leptospirosis’ patients [16], but when it occurs other diag-
nosis must be investigated, such as hematologic disorders
and visceral leishmaniasis, especially in tropical countries.
In a recent study conducted in our region with 374 lepto-
spirosis patients, thrombocytopenia was found in 53.5 % of
patients on admission and it was associated with length of
disease and AKI, but it was not associated with higher mor-
tality [15].
Oliguria is a frequent feature in patients with severe
AKI and it is associated with more frequent pulmonary
involvement and higher mortality in leptospirosis [2, 13,
17–20]. However, in the present study, oliguria was not
associated with ICU admission, since there was no
significant difference in frequency of oliguria between
the two groups. Several hemodynamic changes that
occur in leptospirosis, such as systemic vasodilation,
renal vasoconstriction and elevation of aldosterone,
associated with dehydration secondary to fever, vomiting
and diarrhea could explain the onset of oliguria in lepto-
spirosis patients [4, 21].
Hypotension was found to be a predictor of ICU
admission in our study, according to multivariate analysis.
Hemodynamic changes, such as increased vascular perme-
ability secondary to cytokines and vasoactive mediators
might also explain the onset of hypotension in severe
cases. Low mean arterial pressure is well described as an
important factor for the onset of AKI and disease severity
in leptospirosis patients [22].
It is known that AKI severity in leptospirosis is associ-
ated with higher mortality [17, 23]. RIFLE and AKIN are
good markers for the purpose of stratifying patients’
severity in leptospirosis. Worse AKI stages (RIFLE-F and
AKIN-3) are associated with higher mortality [17]. In
the present study, AKI RIFLE “Failure” was significantly
higher in the ICU group.
The most recognized factors correlating with severity
in leptospirosis are AKI, pulmonary involvement and
electrolyte imbalances [24]. In the present study, inde-
pendent risk factors associated with ICU admission were
hypotension, tachypnea and AKI severity. In a recent
study with 176 leptospirosis patients, independent pre-
dictors of severity were current cigarette smoking (OR
= 2.94 [CI 1.45-5.96]), delay >2 days between the onset
of symptoms and the initiation of antibiotic therapy (OR
= 2.78 [CI 1.31-5.91]) and Leptospira interrogans ser-
ogroup Icterohaemorrhagiae as the infecting strain (OR
= 2.79 [CI 1.26-6.18]) [25]. Another study, conducted
with 101 leptospirosis patients in India, showed that
older age, delayed antibiotic therapy, higher bilirubin,
aspartate aminotransferase, alkaline phosphatase, leuco-
cyte count and aspartate/alanine aminotransferase ratio
(AAR) were univariate predictors of mortality.
Ceftriaxone use was more frequent among patients
admitted to ward and it was shown to be a protect-
ive factor for ICU admission, different from penicil-
lin use, which was not different between groups. The
use of antibiotics in leptospirosis has been widely
debated. Numerous studies have been conducted to
investigate the role of antibiotics in leptospirosis,
with controversial results, and the current consensus
is that antibiotics must be used, since it probably
brings more benefits than harm, reducing the time
of hospital stay, the duration of fever and slowing
disease symptoms in general [26–30]. It is possible
that antibiotics have an important role in immune
response modulation in leptospirosis, which could
partially explain the observation of a better evolution
Table 6 Independent risk factors for ICU admission among
patients with severe leptospirosis (multivariate analysis)
Multivariate analysis p OR/ 95 % CI
Tachypnea 0.027 13 (1.3 – 132)
Hypotension 0.009 5.27 (1.5 – 18)
AKI 0.029 14 (1.3 – 150)
Ceftriaxone 0.001 0.13 (0.04-0.4)
OR odds ratio. 95 % CI: 95 % confidence interval. Logistic regression and
multivariate analysis were performed to make this comparison. P values ≤ 0.05
were considered statistically significant
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in patients treated with penicillin [31–33]. Nonethe-
less, mortality does not seem to be significantly in-
fluenced by antibiotic use [34].
As expected, in the present study, mortality was higher
among ICU patients (23.5 % vs. 5.7 %, p < 0.0001) when
compared to ward group. Some studies performed in
our region have found mortality rates varying from 12 to
20 % in leptospirosis, which were lower than those
found in the present study [35]. Even higher mortality
rates have been described in some cases. In a study per-
formed with 60 leptospirosis ICU patients between 2002
and 2003, mortality was 52 %, which was remarkably
higher than average mortality in that ICU in the period
[36]. These data reinforce the importance of determining
predictors of ICU admission in leptospirosis.
Conclusion
Tachypnea, hypotension and AKI are risk factors for
ICU admission, and ceftriaxone use is a protective fac-
tor. These results alert to early identification of the
above mentioned factors and then a more aggressive
treatment, including early antibiotics use and renal re-
placement therapy when needed to possibly decrease
mortality.
Study limitations
Main limitations of this study derive from its retrospect-
ive nature. Some data from patient’s records were not
available on admission. Urine output and urinalysis were
particularly poorly available in the ward group, since
non-critical care units frequently do not accurately
measure and analyze urine output. Further prospective
studies are then necessary to continue the investigation
of leptospirosis predictors of ICU admission.
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